MedPath

浙江普利药业有限公司

Ownership
-
Established
2003-08-13
Employees
-
Market Cap
-
Website
www.kanoqi.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:25

Drug Approvals

Desloratadine Oral Solution

Product Name
地氯雷他定口服溶液
Approval Number
国药准字H20253993
Approval Date
Apr 22, 2025
NMPA

Linezolid for Oral Suspension

Product Name
利奈唑胺干混悬剂
Approval Number
国药准字H20253003
Approval Date
Jan 2, 2025
NMPA

Amiodarone Hydrochloride Injection

Product Name
盐酸胺碘酮注射液
Approval Number
国药准字H20249443
Approval Date
Nov 22, 2024
NMPA

Silodosin Capsules

Product Name
赛洛多辛胶囊
Approval Number
国药准字H20249444
Approval Date
Nov 22, 2024
NMPA

Amiodarone Hydrochloride Injection

Product Name
盐酸胺碘酮注射液
Approval Number
国药准字H20249442
Approval Date
Nov 22, 2024
NMPA

Calcium Levofolinate Injection

Product Name
左亚叶酸钙注射液
Approval Number
国药准字H20249208
Approval Date
Oct 29, 2024
NMPA

Calcium Levofolinate Injection

Product Name
左亚叶酸钙注射液
Approval Number
国药准字H20249209
Approval Date
Oct 29, 2024
NMPA

Calcium Levofolinate Injection

Product Name
左亚叶酸钙注射液
Approval Number
国药准字H20249210
Approval Date
Oct 29, 2024
NMPA

Calcium Levofolinate Injection

Product Name
左亚叶酸钙注射液
Approval Number
国药准字H20249207
Approval Date
Oct 29, 2024
NMPA

Rupatadine Fumarate Tablets

Product Name
富马酸卢帕他定片
Approval Number
国药准字H20249163
Approval Date
Oct 22, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.